Cargando…

Real-Life Patterns of Exacerbations While on Inhaled Corticosteroids and Long-Acting Beta Agonists for Asthma over 15 Years

Asthma affects more than 300 million people in the world, costs over $80 billion annually in the United States, and is efficaciously treated with inhaled corticosteroids (ICS). To our knowledge, no studies have examined the real-world effectiveness of ICS, including the combination therapy consistin...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGeachie, Michael J., Wang, Alberta L., Lutz, Sharon M., Sordillo, Joanne E., Weiss, Scott T., Tantisira, Kelan G., Iribarren, Carlos, Lu, Meng X., Wu, Ann Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141292/ https://www.ncbi.nlm.nih.gov/pubmed/32197337 http://dx.doi.org/10.3390/jcm9030819

Ejemplares similares

Genome-wide interaction study reveals age-dependent determinants of responsiveness to inhaled corticosteroids in individuals with asthma
por: Dahlin, Amber, et al.
Publicado: (2020)

Predicting Inhaled Corticosteroid Response in Asthma with Two Associated SNPs
por: McGeachie, Michael J., et al.
Publicado: (2012)

Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Kachroo, Priyadarshini, et al.
Publicado: (2021)

Circulating microRNAs and prediction of asthma exacerbation in childhood asthma
por: Kho, Alvin T., et al.
Publicado: (2018)

CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids
por: Dahlin, Amber, et al.
Publicado: (2015)

Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy
por: McGeachie, Michael J., et al.
Publicado: (2020)

Plasmalogens Mediate the Effect of Age on Bronchodilator Response in Individuals With Asthma
por: Sordillo, Joanne E., et al.
Publicado: (2020)

Seasonal Variation in miR-328-3p and let-7d-3p Are Associated With Seasonal Allergies and Asthma Symptoms in Children
por: Tiwari, Anshul, et al.
Publicado: (2021)

Blood miRNAs Are Linked to Frequent Asthma Exacerbations in Childhood Asthma and Adult COPD
por: Tiwari, Anshul, et al.
Publicado: (2022)

CASTER: Cross-Sectional Asthma STEroid Response Measurement
por: Kho, Alvin T., et al.
Publicado: (2020)

Circulating MicroRNA: Incident Asthma Prediction and Vitamin D Effect Modification
por: Li, Jiang, et al.
Publicado: (2021)

Genetic Signatures of Acute Asthma Exacerbation Related With Ineffective Response to Corticosteroid
por: Kang, Min-Gyu, et al.
Publicado: (2020)

Systems Genomics Reveals microRNA Regulation of ICS Response in Childhood Asthma
por: Sharma, Rinku, et al.
Publicado: (2023)

Whole genome prediction and heritability of childhood asthma phenotypes
por: McGeachie, Michael J., et al.
Publicado: (2016)

Pharmacometabolomics of Bronchodilator Response in Asthma and the Role of Age-Metabolite Interactions
por: Kelly, Rachel S., et al.
Publicado: (2019)

An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone
por: Alakeel, Yousif S., et al.
Publicado: (2022)

COPD-associated miR-145-5p is downregulated in early-decline FEV(1) trajectories in childhood asthma
por: Tiwari, Anshul, et al.
Publicado: (2020)

Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
por: Dreher, Michael, et al.
Publicado: (2018)

Genetic Signatures of Asthma Exacerbation
por: Park, Heung-Woo, et al.
Publicado: (2017)

Age by Single Nucleotide Polymorphism Interactions on Bronchodilator Response in Asthmatics
por: Voorhies, Kirsten, et al.
Publicado: (2021)

Pharmacogenetic Polygenic Risk Score for Bronchodilator Response in Children and Adolescents with Asthma: Proof-of-Concept
por: Sordillo, Joanne E., et al.
Publicado: (2021)

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
por: Yang, Hsi-Hsing, et al.
Publicado: (2017)

RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
por: Postma, Dirkje S., et al.
Publicado: (2008)

Retraction Note to: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
por: Postma, Dirkje S., et al.
Publicado: (2009)

Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2022)

Asthma diagnosis and treatment – 1018. Effect of inhaled corticosteroids with long-acting beta2 agonists vs. inhaled corticosteroids alone on asthma control in children: results from national ashtma survey
por: Lockey, Richard F, et al.
Publicado: (2013)

Assessment of genetic factor and depression interactions for asthma symptom severity in cohorts of childhood and elderly asthmatics
por: Park, Heung-Woo, et al.
Publicado: (2018)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β(2)-Agonist–Inhaled Corticosteroid Rescue
por: Lugogo, Njira, et al.
Publicado: (2023)

Circulating MicroRNAs associated with Bronchodilator Response in Childhood Asthma
por: Sharma, Rinku, et al.
Publicado: (2023)

Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
por: Vasbinder, Erwin C, et al.
Publicado: (2016)

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States
por: Averell, Carlyne M., et al.
Publicado: (2022)

Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis
por: Oba, Yuji, et al.
Publicado: (2014)

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
por: Rottenkolber, Marietta, et al.
Publicado: (2015)

Applying the Risk of Bias Tool in a Systematic Review of Combination Long-Acting Beta-Agonists and Inhaled Corticosteroids for Persistent Asthma
por: Hartling, Lisa, et al.
Publicado: (2011)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
por: Scichilone, Nicola, et al.
Publicado: (2014)

Childhood infections and asthma: at the crossroads of the hygiene and Barker hypotheses
por: Tantisira, Kelan G, et al.
Publicado: (2001)

Transcriptome analysis in patients with asthma after inhaled combination therapy with long-acting β2-agonists and corticosteroids
por: Liang, Ya-Ru, et al.
Publicado: (2022)

Association between ADAM33 Single-Nucleotide Polymorphisms and Treatment Response to Inhaled Corticosteroids and a Long-Acting Beta-Agonist in Asthma
por: Vishweswaraiah, Sangeetha, et al.
Publicado: (2023)

Role of Inhaled Corticosteroids for Asthma Exacerbation in Children: An Updated Meta-Analysis
por: Sawanyawisuth, Kanlayanee, et al.
Publicado: (2020)

The association between seasonal asthma exacerbations and viral respiratory infections in a pediatric population receiving inhaled corticosteroid therapy with or without long-acting beta-adrenoceptor agonist: A randomized study()
por: Prazma, Charlene M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gk3s4sb4h6s4stlprv7fbk7fv4